Peter Mitchell
- News
Polypill promises?
Can combination 'polypills' fulfil their promise to offer effective all-in-one treatments?
- Feature
Pushing the boundaries
One drug can be useful for many different conditions - some of which it isn't licensed for. Peter Mitchell finds out how far is too far when it comes to off-label promotion
- News
Regulator rebuffs Merck's cholesterol drug
The US Food and Drug Administration (FDA) has unexpectedly refused to approve Merck's cholesterol-lowering drug Cordaptive
- News
AvastinApprovalRaisesHopesEyebrows
The US Food & Drug Administration (FDA) has approved the Genentech/Roche medicine Avastin for treatment of late-stage breast cancer
- News
UK drug pricing system scrapped
Pharmaceutical price regulation scheme will be replaced by more stringent controls
- News
European patents set to get cheaper
London agreement on translation of patents set to be ratified within months after France drops its opposition
- News
Newly identified side to global warming
An atmospheric mechanism has emerged that could lift global temperatures even higher than current predictions
- Review
Life, the universe and mitochondria
Power, sex and suicide. Mitochondria and the meaning of life